News | News By Subject | News by Disease News By Date | Search News

Pneumonia News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
FDA Clears Expanded Approval of Pfizer (PFE)'s Best-Selling Pneumonia Vaccine     7/13/2016
Bayer (BAY) Terminates Phase II Study With Riociguat In Patients with PH-IIP     5/12/2016
Analysts Take a Peek at Pfizer (PFE)'s 2015 Drug Sales, With a Few Surprises     12/31/2015
Genocea (GNCA) Halts Pneumococcal Vaccine Development After Drug Flunks Phase II Study     10/19/2015
Cempra Pharmaceuticals, Inc. (CEMP) Surges as Lead Oral Antibiotic Meets Main Goal in Phase 3 Study     1/5/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Requests More Data For Basilea Pharmaceutica (BSLN.SW)'s Pneumonia Drug Ceftobiprole; Stock Drops -8.15% At Market Close (June 25, 2014)     6/25/2014
Pfizer Inc. (PFE) Vaccine Prevents Pneumonia In Landmark Study     3/14/2014
Pfizer Inc. (PFE) Touts Positive Results In Pneumonia Vaccine Post-Approval Study     2/24/2014
FDA Warns Pfizer Inc. (PFE)'s Drug Tygacil Raises Risk of Death     9/30/2013
GlaxoSmithKline (GSK) Submits New Application for Synflorix in EU     9/18/2012
FDA Panel OKs Johnson & Johnson (JNJ)’s Levaquin For Treating Pneumonic Plague     4/5/2012
Paratek Pharmaceuticals, Inc. Wins Agreement With FDA on Special Protocol Assessment (SPA) for Phase 3 Study in Community-Acquired Bacterial Pneumonia (CABP)     3/28/2012
Pfizer Inc. (PFE)'s Prevnar 13® for Use in Adults Faces Setback, FDA Panel May Not Vote on Drug Until 2013     2/23/2012

News from Around the Web
Why Doctors Without Borders Is Turning Down A Million Free Pneumonia Vaccines From Pfizer (PFE)     10/12/2016
Simple Breath Test Could Detect Pneumonia, Reducing Chances Of Antibiotic Overuse, Zhejiang University Study     6/9/2016
Why Chinese Parents Are Shopping For Vaccines In Hong Kong     4/13/2016
Tufts University Study Shows Zinc Supplement Boosted Serum Zinc Levels And Immunity In Older Adults     1/29/2016
Prolonged TV Watching Linked To Eight Leading Causes Of Death, American Journal of Preventive Medicine Publishes     10/28/2015
7 Dead In NYC Legionnaires' Disease Outbreak     8/5/2015
New Breath Test For Pneumonia, University of Manchester Study     6/26/2015
Windshield Washer Fluid Linked To Deadly Disease, Arizona State University Study     5/20/2014
Inhaled Meds May Save COPD/Pneumonia Patients' Lives, Veterans Evidence Study     4/21/2011
Flu Helps Spread Pneumonia, Radboud University Nijmegen Medical Centre Finds     4/11/2011
Study Finds Statins Reduce Pneumonia Death Rates, London School of Hygiene and Tropical Medicine Reveals     4/5/2011
For Young Kids With Pneumonia, Timing of Antibiotic Critical: Nationwide Children's Hospital Study     4/1/2011
Vitamin E May Increase or Decrease the Risk of Pneumonia, Depending on Smoking and Exercise, University of Helsinki Study     2/24/2011
Outpatient CAP Rates in Kids Unchanged by Vax, Children's Hospital of Philadelphia Study Finds     2/14/2011
Pneumonia Vaccine 'To Save Thousands of Lives,' Says GAVI Alliance     1/24/2011

Press Releases
Pfizer Canada Release: National Advisory Committee On Immunization (NACI) Gives Prevnar 13 Grade A Recommendation     11/16/2016
Pfizer (PFE) Offers Cut-Price Pneumonia Shot For Humanitarian Crises     11/11/2016
American Osteopathic Association Release: Osteopathic Manipulative Treatment Shown To Reduce Hospital Stay, Mortality Rates In Elderly Patients With Pneumonia     8/29/2016
Combioxin Escalates To High Dose In CAL02-001 Trial In Patients With Severe Pneumococcal Pneumonia Following IDMC's Positive Recommendation     8/9/2016
Theravance Biopharma (TBPH) To Present New Data Demonstrating Potent In Vitro Activity For VIBATIV (Telavancin) Against Difficult-To-Treat Infections, Including MRSA, At 2016 ECCMID Conference     4/4/2016
First Patient Enrolled In Combioxin’s First-In-Man Study With CAL02 In Patients With Severe Pneumococcal Pneumonia     3/23/2016
Covalon Technologies Ltd. Licenses Intellectual Property To Prevent Ventilator-Associated Pneumonia From The University of Michigan     2/9/2016
Combioxin Receives Clinical Trial Authorization To Initiate A First-In-Man Study With CAL02 In Patients With Severe Pneumococcal Pneumonia     1/12/2016
Aridis Pharmaceuticals Reports Positive Phase 1 Clinical Results For Aerucin For Treating Hospital-Acquired And Ventilator-Associated Pneumonia     1/7/2016
TaiGen Biotechnology's Intravenous Taigexyn Successfully Achieved Primary Endpoint In Phase 3 Clinical Trial For Community Acquired Pneumonia     12/3/2015
Nektar Therapeutics (NKTR) To Present At Jefferies Autumn 2015 Global Healthcare Conference In London     11/17/2015
Paratek Pharmaceuticals, Inc. Reports Third Quarter 2015 Financial And Operating Results     11/12/2015
Paratek Pharmaceuticals, Inc. Initiates Omadacycline Phase III Clinical Study In Community Acquired Bacterial Pneumonia (CABP)     11/9/2015
Nektar Therapeutics (NKTR) To Announce Financial Results For The Third Quarter 2015 On Thursday, November 5, 2015, After Close Of U.S.-Based Financial Markets     10/30/2015
Paratek Pharmaceuticals, Inc.'s Omadacycline, Demonstrates Broad Spectrum Activity In Pathogens Relevant In Skin Infections, Community-Acquired Pneumonia And Urinary Tract Infections     9/21/2015

//-->